ELVN
NASDAQ · Pharmaceuticals
Enliven Therapeutics Inc
$34.51
+3.36 (+10.79%)
Open$33.77
Previous Close$31.15
Day High$35.70
Day Low$33.76
52W High$30.63
52W Low$13.30
Volume—
Avg Volume750.2K
Market Cap1.75B
P/E Ratio—
EPS$-1.85
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
-8.2% upside
Current
$34.51
$34.51
Target
$31.67
$31.67
$20.91
$31.67 avg
$36.06
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 263.34M | 235.73M | 210.63M |
| Net Income | 79.58M | 63.75M | 57.56M |
| Profit Margin | 30.2% | 27.0% | 27.3% |
| EBITDA | 141.73M | 119.11M | 111.32M |
| Free Cash Flow | 52.28M | 61.02M | 35.31M |
| Rev Growth | -0.5% | +12.7% | -7.4% |
| Debt/Equity | 0.42 | 0.43 | 0.43 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |